SARS-CoV-2-IN-75
SARS-CoV-2-IN-75 (compound 13) is a SARS-CoV-2 inhibitor based on chloroacetamide inhibition. SARS-CoV-2-IN-75 inhibits cellular SARS-CoV-2 replication with an EC68 (half-log reduction in viral titer) of 3 μM[1].
Product Specifications
CAS Number
2738323-08-3
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-75.html
Solubility
10 mM in DMSO
Smiles
O=C(NC(C)(C)C)C(N(C1=CC=C(C(C)(C)C)C=C1)C(CCl)=O)C2=CC=CN=C2
Molecular Formula
C23H30ClN3O2
Molecular Weight
415.96
References & Citations
[1]Ashraf-Uz-Zaman M, et al. Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease. ACS Infect Dis. 2024 Jan 8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC400833 20 µg
Galectin 1 (LGALS1) (NM_002305) Human Over-expression Lysate
Sign In for Pricing
View Details 
